doi:10.1007/s11064-023-04000-z Nasca C, Xenos D, Barone Y, et al
GLP-1 RAs have been found to improve body weight, blood pressure (BP), lipid profile levels, and myocardial infarction (MI) outcomes even in nondiabetic patients without increasing the risk of hypoglycemic events ( Our narrative review aimed to discuss the CV benefits of GLP-1 RAs in terms of controlling CV risk factors and improving HF outcomes, and the CV perspectives related to their use in clinical practice
Clinical studies on skin and connective tissues generally evaluate daily intake over several weeks , which highlights a key point: the expected effects are linked to a regular strategy, rather than a one-off "boost"
All studies incorporated lifestyle counseling, but the intensity and structure of these interventions may have differed
With traditional minimally invasive surgery, the incision is smaller
It is an offence in Victoria to possess or sell peptides without authorisation per s 36B(2) of the Drugs, Poisons and Controlled Substances Act 1981
